ATTD Diabetes Technology Conference Paris 2027

Dates: 3–6 March 2027
Venue: Palais des Congrès de Paris, Paris, France
Full name: The 20th International Conference on Advanced Technologies & Treatments for Diabetes.

ATTD brings together scientific discussion of diabetes treatment and technology with a dedicated Tech Fair for start-ups, emerging companies and research centres. Its published topics cover glucose monitoring, insulin delivery, artificial intelligence, clinical decision support, treatment and prevention.

ATTD 2027 at a glance

The official 2027 site confirms the dates, Paris venue and topic list. The latest published attendee profile is for 2026.

Why ATTD matters to diabetes professionals

Connect research with clinical practice

ATTD spans technologies and treatments that influence glucose monitoring, insulin delivery, decision support and prevention. Clinicians can compare evidence and questions across care settings rather than viewing devices in isolation.

Follow technology and treatment developments

Published topics include continuous glucose monitoring, sensors, pumps, closed-loop systems, artificial pancreas, new insulins, diabetes medicines, obesity treatments, AI and telemedicine. The 2026 attendee profile lists 1,976 attendees from 40 countries. These are organiser-published figures, not an independently audited count.

Bring developers and care teams into the same discussion

The Tech Fair is presented for start-ups, emerging companies and research centres with diabetes devices and digital solutions. Developers can present innovations and discuss them with healthcare professionals and researchers; clinicians can examine technology alongside scientific topics.

Diabetes technology and treatment topics at ATTD

Glucose monitoring and sensors

• Continuous glucose monitoring in practice
• Interstitial glucose measurement
• Glucose sensors
• Hospital glucose monitoring

Insulin delivery and automated systems

• Insulin pumps
• Inhaled, transdermal and implanted insulin delivery systems
• Closed-loop systems and algorithms
• Artificial pancreas

Artificial intelligence, software and decision support

• Artificial intelligence and diabetes
• AI in detection of chronic diabetes complications
• AI in electronic records and data management
• Big-data and AI-based decision-support systems
• Clinical decision-support systems and advisors
• Telemedicine and medical software

Medicines and treatment technologies

• New insulins
• New medicines for diabetes
• Medicines for treating obesity
• Technologies for treating obesity

Screening, prevention and care contexts

• Screening and prevention of type 1 diabetes
• Screening and prevention of type 2 diabetes
• Technology and pregnancy
• Technology use in older adults
• Physical activity and nutrition

Who should visit ATTD Diabetes Technology Conference Paris?

Clinicians and diabetes-care teams

Useful if your work involves diabetes treatment, technology adoption or patient care. Prioritise topics relevant to your current clinical questions:

• Continuous glucose monitoring and sensor use
• Insulin pumps and automated delivery
• Clinical decision support and AI
• Technology use in hospitals, pregnancy or older age
• New treatments and prevention

Diabetologists, endocrinologists and other healthcare professionals can compare research across these areas and identify questions to assess in their own practice.

Researchers and scientists

Useful if you conduct clinical, translational or technology research in diabetes. Topics include trials in progress, data management, chronic complications, treatment, monitoring and prevention. Researchers can identify related work and consider how findings connect with clinical use.

Start-ups, emerging companies and research centres

Useful if you are developing a diabetes medical device or digital solution and want to present it to a professional audience. The Tech Fair is designed for early-stage companies and research centres; check current terms before committing.

Why visit ATTD Diabetes Technology Conference Paris?

1. Compare continuous glucose monitoring and sensor approaches against clinical or research priorities.
2. Follow developments in pumps, insulin delivery, closed-loop algorithms and artificial-pancreas systems.
3. Examine how AI, medical data and decision-support research relate to diabetes care.
4. Review research spanning diabetes treatment, obesity, screening and prevention.
5. Discuss medical-device and digital-health ideas with clinicians, researchers and developers.

Why exhibit at ATTD Diabetes Technology Conference Paris?

The Tech Fair is aimed at start-ups, emerging companies and research centres presenting diabetes devices and digital solutions. The organiser lists a 4 sqm package priced at EUR 800 (+VAT), including a backwall, side walls, table, chairs, company name, two exhibitor badges, a 10-minute presentation during coffee breaks and a virtual booth in the ATTD Tech Hub. It also lists visibility in conference materials and access to the Ignite Networking Event. Confirm current package availability and terms with the organiser.

For a company entering or expanding in France, assess clinical evidence, intended use, regulatory requirements, reimbursement conditions, distribution and support needs for each product. Public information reviewed does not establish a sales outcome or a diabetes-device market size.

How to prepare before ATTD Diabetes Technology Conference Paris

1. Set a focused objective

Choose a clinical, research or commercial question before reviewing the topics. A care team might focus on sensor integration, while a developer may want to explore evidence requirements and use cases.

2. Match the topics to your work

Use the published abstract topics to identify relevant areas, then check the organiser’s programme and registration information for updates. A topic heading does not guarantee a particular session format or speaker.

3. Prepare targeted questions

• Which patient or care context is the technology designed for?
• What evidence supports its accuracy, safety and intended use?
• How does it connect with existing monitoring, insulin-delivery or clinical data systems?
• What training, workflow and follow-up does implementation require?
• For a product intended for France, what listing, reimbursement and eligibility conditions apply?

4. Plan participation around the format

Check current attendee registration, the conference agenda and Tech Fair terms with the organiser. Confirm required materials, eligibility and deadlines before making travel or budget commitments.

ATTD visitor profile and professional interests

How many days should you plan for ATTD?

The 2027 conference runs across four days. The right amount of time depends on whether your priority is scientific sessions, the Tech Fair or both. Review the programme when planning your schedule and leave room to follow up on relevant discussions.

After ATTD: turn information into next steps

Sort information into evidence or clinical questions to review now, technologies for deeper assessment, and contacts or ideas to revisit later. For a device or digital solution, record its intended use, evidence base, interoperability, reimbursement questions and the next information required. Follow up with specific questions rather than relying on a general impression.

Is ATTD Diabetes Technology Conference Paris worth attending?

ATTD is most relevant to diabetes clinicians, researchers and technology developers with a clear interest in monitoring, treatment, prevention or clinical technology. Its range of topics and dedicated Tech Fair can support focused comparison and discussion. Value depends on selecting relevant topics and checking current participation details with the organiser.

Closing thought

What question about diabetes technology or treatment do you want to answer through evidence and professional exchange? Arrive with a focus; leave with a decision, a research direction or questions to pursue. Review. Compare. Discuss. Follow up.

Diabetes technology and treatment opportunities in France

Market indicators

Santé publique France reports that pharmacologically treated diabetes affected an estimated 5.6% of the population in 2023, or more than 3.8 million people. This is a health indicator, not a valuation of the diabetes-device market. The same source says 7.1% of adults aged 18–79 reported diabetes in 2024.

• Pharmacologically treated diabetes: estimated 5.6% of the population, more than 3.8 million people, 2023.
• Self-reported diabetes among adults aged 18–79: 7.1%, 2024.

Clinical and commercial areas to assess

These indicators provide context for clinical relevance but do not establish product-level demand or sales. Companies may investigate continuous glucose monitoring and interstitial-glucose devices against clinical needs and coverage conditions. Developers of insulin-delivery, closed-loop and decision-support technologies may use professional discussions to test clinical relevance and evidence priorities.

Reimbursement and market-entry conditions

Assurance Maladie states that several interstitial-glucose monitoring devices are covered after listing on the LPP, which began for the first device in 2027. Coverage is subject to product and patient eligibility conditions; manufacturers and distributors should verify the current listing and criteria for each device.

What this may mean for exhibitors

Diabetes-technology exhibitors may use ATTD to discuss clinical use, evidence and reimbursement questions. The event does not guarantee buyer access or a commercial result, and prevalence figures should not be treated as a forecast of device sales.

What this may mean for visitors

Clinicians and buyers may compare monitoring and treatment approaches against care requirements, then verify evidence, interoperability and French coverage conditions before evaluating adoption.

How ilikevents can help you at ATTD Diabetes Technology Conference Paris

Whether you are attending for clinical insight, research exchange or a technology showcase, ilikevents can help organise practical steps around your participation.

For visitors

• Conference visit planning around your clinical or research objectives
• Flight and hotel arrangements
• Visa application assistance
• Airport transfers and local transportation
• Interpreter and business guide services
• Ticket and registration assistance
• Business meeting coordination

For exhibitors

• Exhibition registration and organiser coordination
• Stand selection and participation planning
• Booth design and construction
• Exhibition staffing and interpretation
• Promotional materials and advertising
• Business meeting arrangements
• Local market research and distributor identification
• Accommodation, flights and transportation

Explore Event Opportunities

Explore how ATTD participation could support your clinical, research or diabetes-technology objectives with practical planning from ilikevents.

Get Expert Assistance from ilikevents to plan your visit or participation.